Demand for Temperature Control Systems to Gain Strength in Biobanking Market
Growing trend of personalised medicines to reduce mortality rates caused by chronic diseases is fuelling demand for biobanks for the effective storage of numerous biospecimen, ranging from blood to tissues, cells, and nucleic acids. Sales of equipment for storing biospecimen would surge, and temperature control systems are projected to cross the US$ 1 Bn mark by 2027. A notable spurt in adoption of freezers for the preservation of biospecimen for their future use is likely to underpin growth of temperature control systems. However, a shift from manual to automated systems would boost opportunities for software and services during the forecast period (2020-2027).
A recent study on the biobanking market has been added to the broad repository of Fact.MR. According to the study, the biobanking market would advance at a healthy CAGR of 7% during the forecast period.
For detailed insights on market taxonomy, request a sample copy of the report here.
High Operational Cost Concerns Portend Limited Adoption of Biobank Products
According to the study, technological advancements present a crucial challenge associated with cost. Integration of advanced technology means high cost of equipment and consumables, which, in turn, increases the operational costs of biobanks. For instance, in France and the Netherlands, the annual operational cost of a biobank ranges from US$ 220,000 to US$ 880,000. Besides this, cost associated with infrastructure, equipment, human resources, and supplies further make it an expensive working model. The high operational cost of biobanks reflects on the increasing price of storage for end users, which is leading to a low adoption rate of biobanks.
Therapeutics to Grow as Leading Application in Biobanking Market
There has been a shift in the healthcare sector from chemicals towards biospecimen for the development of therapeutics to treat chronic and rare disorders. This is gradually boosting demand for blood products, tissues, and human cells for the development of precision and regenerative medicines.
On account of this shift, therapeutics are expected to account for 38% share in the biobanking market by 2027. However, as healthcare professionals are looking at preventive rather than a curative approach, use of biospecimen for clinical diagnosis is likely to increase at a CAGR of around 7% during the forecast period. Several research institutes help clinics by studying cell structures to determine the root of chronic diseases, which is projected to strengthen sales from the clinical diagnosis of biospecimen.
For detailed regional analysis, request a sample copy of the report here.
Asia Pacific Biobanking Market Surge Driven by China
There has been an increase in the number of biobanks in developing as well as developed countries of Asia Pacific, such as China, Japan, Singapore, South Korea, Thailand, and Australia. A significant thrust to the Asia Pacific biobanking market is offered by China, on account of ongoing advancements in the pharmaceutical industry, which is likely to increase demand for biospecimen for producing therapeutics. Government initiatives in the healthcare sector towards improving extant infrastructure through monetary aids, are, in turn, expanding the scope of the industry. In addition, there has been an increase in the number of biobanks in China, which holds a high potential to drive the sales of biobank products. On the back of China’s notable performance in the biobanking market, Asia Pacific is expected to witness the highest CAGR of around 8% during the forecast period.
Biobanking Market – Scope of the Study
The study on the biobanking market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that are driving the growth of the market. This exclusive study provides incisive insights regarding recent developments in the biobanking market, by analysing the historical data for the period of 2017-2019, with the duration of 2020-2027 being considered as the forecast period.
Evaluation of the biobanking market’s revenue has been carried out in terms of value (US$ Mn). This research provides information into the key trends that are potential enough to influence the growth of the biobanking market. Besides this, the study also includes several macroeconomic and microeconomic growth indicators complementing the growth of the biobanking market during the forecast period. This detailed study provides information into key dynamics, and their influence on the biobanking market during the forecast period.
The report also provides information about the key challenges and threats that could deter the growth potential of players in the biobanking market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global biobanking market. With a view of aiding stakeholders in the biobanking market, the study comprises a detailed section on the competition analysis.
This exclusive study offers a dashboard view of the biobanking market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the biobanking market have also been included in this comprehensive study.
Biobanking Market – Assessment of Key Segments
Authors of this comprehensive study have classified the biobanking market into key segments for an in-depth study of the biobanking market. Categorisation of the biobanking market is based on storage, application, biospecimen, product, and region. This detailed study also offers information about the incremental opportunity present in the biobanking market during the forecast period. Key segments considered while studying the biobanking market include:
|
Storage |
Application |
Biospecimen |
Product |
Region |
|
Manual |
Therapeutics |
Blood Products |
Equipment
|
North America |
|
Automated |
Clinical Diagnostics |
Human Tissues |
Consumables
|
Europe |
|
|
Drug Discovery & Development |
Cell Lines |
Software & Services |
Asia Pacific |
|
|
Others |
Nucleic Acids |
|
Latin America |
|
|
|
Others |
|
Middle East & Africa |
Revenue of the biobanking market has been evaluated in terms of US$ Mn for the period of 2020 to 2027. In addition to this, compound annual growth rate has been calculated for all key segments for the forecast period of 2020-2027, considering 2019 as the base year.
Authors of this exclusive study on the biobanking market have analysed key players, based on their financials, products, and strategies, in order to provide key detailed information into the competitive landscape. Key players operating in the biobanking market include Thermo Fisher Scientific, Inc., Tecan Trading AG, PHC Holdings Corporation (Panasonic Healthcare), Merck KGaA, Hamilton Company, Brooks Automation, Inc., Chart Industries, Inc., Greiner AG, VWR International, LLC, and QIAGEN N.V.
This exclusive study is produced to offer a detailed perspective of the biobanking market to stakeholders. The report is also aimed at offering crucial information about the biobanking market to new players.
Request research methodology of this report.
Biobanking Market – Research Methodology
The primary objective of this exclusive study on the biobanking market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2027. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the biobanking market, and the adoption rate of biobanking in key regions across the world.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Biobanking Market: Market Snapshot
4. Market Overview
4.1. Global Biobanking Market: Product Overview
4.2. Global Biobanking Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biobanking Market Revenue Projections, 2020–2027
4.5. Global Biobanking Market Outlook
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Healthcare Industry Overview
5.4. Regulatory Scenario by Region/globally
5.5. List of Major Biobanks, by Region
5.6. List of Vendors Supporting Automated Biobanking
6. Global Biobanking Market Analysis, by Product
6.1. Key Findings
6.2. Introduction
6.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Product
6.4. Global Biobanking Market Forecast, by Product
6.4.1. Equipment
6.4.1.1. Temperature Control Systems
6.4.1.1.1. Freezers & Refrigerators
6.4.1.1.2. Cryogenic Storage Systems
6.4.1.1.3. Thawing Equipment
6.4.1.1.4. Incubators & Centrifuges
6.4.1.2. Alarms & Monitoring Systems
6.4.1.3. Accessories & Other equipment
6.4.2. Consumables
6.4.2.1. Cryovials & Cryomolds
6.4.2.2. Tubes
6.4.2.3. Others
6.4.3. Software & Services
6.5. Global Biobanking Market Analysis, by Product, 2020–2027
7. Global Biobanking Market Analysis, by Biospecimen
7.1. Key Findings
7.2. Introduction
7.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
7.4. Global Biobanking Market Forecast, by Biospecimen
7.4.1. Blood Products
7.4.2. Human Tissues
7.4.3. Cell Lines
7.4.4. Nucleic Acids
7.4.5. Others
7.5. Global Biobanking Market Analysis, by Biospecimen, 2020–2027
8. Global Biobanking Market Analysis, by Application
8.1. Key Findings
8.2. Introduction
8.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Application
8.4. Global Biobanking Market Forecast, by Application
8.4.1. Therapeutics
8.4.2. Clinical Diagnostics
8.4.3. Drug Discovery & Development
8.4.4. Others
8.5. Global Biobanking Market Analysis, by Application, 2020–2027
9. Global Biobanking Market Analysis, by Storage
9.1. Key Findings
9.2. Introduction
9.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Storage
9.4. Global Biobanking Market Forecast, by Storage
9.4.1. Manual
9.4.2. Automated
9.5. Global Biobanking Market Analysis, by Storage, 2020–2027
10. Global Biobanking Market Analysis, by Region
10.1. Global Biobanking Market Scenario, by Country
10.2. Global Biobanking Market Value Share and Attractiveness Analysis, by Region
10.3. Global Biobanking Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Biobanking Market Analysis
11.1. Key Findings
11.2. North America Biobanking Market Value Share and Attractiveness Analysis, by Country
11.3. North America Biobanking Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Biobanking Market Value Share and Attractiveness Analysis, by Product
11.5. North America Biobanking Market Forecast, by Product
11.5.1. Equipment
11.5.1.1. Temperature Control Systems
11.5.1.1.1. Freezers & Refrigerators
11.5.1.1.2. Cryogenic Storage Systems
11.5.1.1.3. Thawing Equipment
11.5.1.2. Incubators & Centrifuges
11.5.1.3. Alarms & Monitoring Systems
11.5.1.4. Accessories & Other equipment
11.5.2. Consumables
11.5.2.1. Cryovials & Cryomolds
11.5.2.2. Tubes
11.5.2.3. Others
11.5.3. Software & Services
11.6. North America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
11.7. North America Biobanking Market Forecast, by Biospecimen
11.7.1. Blood Products
11.7.2. Human Tissues
11.7.3. Cell Lines
11.7.4. Nucleic Acids
11.7.5. Others
11.8. North America Biobanking Market Value Share and Attractiveness Analysis, by Application
11.9. North America Biobanking Market Forecast, by Application
11.9.1. Therapeutics
11.9.2. Clinical Diagnostics
11.9.3. Drug Discovery & Development
11.9.4. Others
11.10. North America Biobanking Market Value Share and Attractiveness Analysis, by Storage
11.11. North America Biobanking Market Forecast, by Storage
11.11.1. Manual
11.11.2. Automated
12. Europe Biobanking Market Analysis
12.1. Key Findings
12.2. Europe Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Biobanking Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Biobanking Market Value Share and Attractiveness Analysis, by Product
12.5. Europe Biobanking Market Forecast, by Product
12.5.1. Equipment
12.5.1.1. Temperature Control Systems
12.5.1.1.1. Freezers & Refrigerators
12.5.1.1.2. Cryogenic Storage Systems
12.5.1.1.3. Thawing Equipment
12.5.1.2. Incubators & Centrifuges
12.5.1.3. Alarms & Monitoring Systems
12.5.1.4. Accessories & Other equipment
12.5.2. Consumables
12.5.2.1. Cryovials & Cryomolds
12.5.2.2. Tubes
12.5.2.3. Others
12.5.3. Software & Services
12.6. Europe Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
12.7. Europe Biobanking Market Forecast, by Biospecimen
12.7.1. Blood Products
12.7.2. Human Tissues
12.7.3. Cell Lines
12.7.4. Nucleic Acids
12.7.5. Others
12.8. Europe Biobanking Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Biobanking Market Forecast, by Application
12.9.1. Therapeutics
12.9.2. Clinical Diagnostics
12.9.3. Drug Discovery & Development
12.9.4. Others
12.10. Europe Biobanking Market Value Share and Attractiveness Analysis, by Storage
12.11. Europe Biobanking Market Forecast, by Storage
12.11.1. Manual
12.11.2. Automated
13. Asia Pacific Biobanking Market Analysis
13.1. Key Findings
13.2. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Biobanking Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Product
13.5. Asia Pacific Biobanking Market Forecast, by Product
13.5.1. Equipment
13.5.1.1. Temperature Control Systems
13.5.1.1.1. Freezers & Refrigerators
13.5.1.1.2. Cryogenic Storage Systems
13.5.1.1.3. Thawing Equipment
13.5.1.2. Incubators & Centrifuges
13.5.1.3. Alarms & Monitoring Systems
13.5.1.4. Accessories & Other equipment
13.5.2. Consumables
13.5.2.1. Cryovials & Cryomolds
13.5.2.2. Tubes
13.5.2.3. Others
13.5.3. Software & Services
13.6. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
13.7. Asia Pacific Biobanking Market Forecast, by Biospecimen
13.7.1. Blood Products
13.7.2. Human Tissues
13.7.3. Cell Lines
13.7.4. Nucleic Acids
13.7.5. Others
13.8. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Biobanking Market Forecast, by Application
13.9.1. Therapeutics
13.9.2. Clinical Diagnostics
13.9.3. Drug Discovery & Development
13.9.4. Others
13.10. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Storage
13.11. Asia Pacific Biobanking Market Forecast, by Storage
13.11.1. Manual
13.11.2. Automated
14. Latin America Biobanking Market Analysis
14.1. Key Findings
14.2. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Biobanking Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Product
14.5. Latin America Biobanking Market Forecast, by Product
14.5.1. Equipment
14.5.1.1. Temperature Control Systems
14.5.1.1.1. Freezers & Refrigerators
14.5.1.1.2. Cryogenic Storage Systems
14.5.1.1.3. Thawing Equipment
14.5.1.2. Incubators & Centrifuges
14.5.1.3. Alarms & Monitoring Systems
14.5.1.4. Accessories & Other equipment
14.5.2. Consumables
14.5.2.1. Cryovials & Cryomolds
14.5.2.2. Tubes
14.5.2.3. Others
14.5.3. Software & Services
14.6. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
14.7. Latin America Biobanking Market Forecast, by Biospecimen
14.7.1. Blood Products
14.7.2. Human Tissues
14.7.3. Cell Lines
14.7.4. Nucleic Acids
14.7.5. Others
14.8. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Biobanking Market Forecast, by Application
14.9.1. Therapeutics
14.9.2. Clinical Diagnostics
14.9.3. Drug Discovery & Development
14.9.4. Others
14.10. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Storage
14.11. Latin America Biobanking Market Forecast, by Storage
14.11.1. Manual
14.11.2. Automated
15. Middle East & Africa Biobanking Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Biobanking Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Product
15.5. Middle East & Africa Biobanking Market Forecast, by Product
15.5.1. Equipment
15.5.1.1. Temperature Control Systems
15.5.1.1.1. Freezers & Refrigerators
15.5.1.1.2. Cryogenic Storage Systems
15.5.1.1.3. Thawing Equipment
15.5.1.2. Incubators & Centrifuges
15.5.1.3. Alarms & Monitoring Systems
15.5.1.4. Accessories & Other equipment
15.5.2. Consumables
15.5.2.1. Cryovials & Cryomolds
15.5.2.2. Tubes
15.5.2.3. Others
15.5.3. Software & Services
15.6. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen
15.7. Middle East & Africa Biobanking Market Forecast, by Biospecimen
15.7.1. Blood Products
15.7.2. Human Tissues
15.7.3. Cell Lines
15.7.4. Nucleic Acids
15.7.5. Others
15.8. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Biobanking Market Forecast, by Application
15.9.1. Therapeutics
15.9.2. Clinical Diagnostics
15.9.3. Drug Discovery & Development
15.9.4. Others
15.10. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Storage
15.11. Middle East & Africa Biobanking Market Forecast, by Storage
15.11.1. Manual
15.11.2. Automated
16. Competition Landscape
16.1. Company Profiles
16.1.1. Thermo Fisher Scientific, Inc.
16.1.2. PHC Holdings Corporation (Panasonic Healthcare)
16.1.3. Hamilton Company
16.1.4. Chart Industries, Inc.
16.1.5. VWR International, LLC. (Avantor, Inc.)
16.1.6. QIAGEN N.V.
16.1.7. Greiner AG
16.1.8. Brooks Automation, Inc.
16.1.9. Merck KGaA
16.1.10. Tecan Trading AG
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Biobanking Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027